Terug naar events

4th Conference on Next Generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animal

4th Conference on Next Generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animal
EVENT DETAILS
EVENT DETAILS
Date
03 -05 December 2024
Address
Frankfurt, Germany
Organizer
IABS
Website

Event by IABS

Objectives of the meeting

2024 is a key year for globally considering NGS implementation with the recent publication of the revised ICHQ5A(R2) guideline and the upcoming draft chapter on NGS from the EDQM/European Pharmacopoeia. 

The 4th NGS meeting will continue to highlight current scientific data and knowledge with focus on NGS implementation for adventitious virus detection in biological products. Discussions will include capabilities of NGS for virus detection in different matrices and validation of the technical and bioinformatics steps involved in NGS for its applications in characterization and safety evaluation of biologics such as vaccines for human and veterinary use, gene and cell therapy products, and biotherapeutics.

The meeting will bring together representatives from industry, academia, technology providers, and international regulatory bodies for discussing the current applications of NGS as an alternative method for replacing or supplementing the current conventional assays for detection of adventitious viruses in biologics.

A one-day NGS training workshop (December 3rd) to be associated to this conference (December 4th & 5th) is in preparation and further details will be communicated soon.

Scientific Committee

  • Arifa S. Khan – Co-chair, FDA-CBER (FDA), U.S.A.
  • Laurent Mallet – Co-chair, EDQM, France
  • Pieter Neels –  IABS Chair, Belgium
  • Johannes Blümel – PEI, Germany
  • Noémie Deneyer – GSK, Belgium
  • Sigrid De Keersmaecker – Sciensano, Belgium
  • Blandine De Saint-Vis – Boehringer- Ingelheim, France
  • Ivana Knezevic – WHO, Switzerland
  • Carine Logvinoff – Sanofi Pasteur, France
  • Marie Murphy – Eli Lilly, Ireland
  • Siemon Ng – Notch Therapeutics, Canada
  • Yoji Sato – National Institute of Health Sciences – Japan
  • Michael Wall – Health Canada, Canada

Organising Committee

  • Arifa S. KHAN – Co-chair, FDA-CBER (FDA), U.S.A.
  • Laurent MALLET – Co-chair, EDQM, France
  • Pieter NEELS – IABS Chair, Belgium
  • Madinina COX – IABS Secretariat, France
  • Marlène LOUIS – IABS Secretariat, France

 

More information: https://events.iabs.org/4th-ngs-conference